Table 2.
Persistent symptoms lasting at least 3 months reported in children with or without previous SARS-CoV-2 infection.
| COVID-19 (N = 639) | Non-COVID-19 (N = 577) | P-valueb | |
|---|---|---|---|
| Mental health | |||
| Anxietya | 34 (9) | 54 (12) | 0.142 |
| Mood swingsa | 29 (7) | 50 (11) | 0.076 |
| Depressiona | 26 (7) | 32 (7) | 0.999 |
| Neurological | |||
| Headachea | 59 (15) | 10 (2) | <0.001 |
| Seizures | 11 (2) | 1 (0.2) | 0.007 |
| Dizzinessa | 19 (5) | 2 (0.4) | <0.001 |
| Sensory problems | |||
| Loss of smella | 33 (9) | 0 | <0.001 |
| Loss of tastea | 30 (8) | 1 (0.2) | <0.001 |
| Loss of appetite | 41 (6) | 12 (2) | <0.001 |
| Cognition | |||
| Forgetfulnessa | 17 (4) | 20 (4) | 0.999 |
| Difficulty concentrationa | 29 (7) | 38 (9) | 0.612 |
| Gastrointestinal | |||
| Diarrhea or constipation | 26 (4) | 12 (2) | 0.049 |
| Nausea or vomiting | 12 (2) | 3 (0.5) | 0.038 |
| Respiratory | |||
| Dyspnea | 26 (4) | 5 (1) | <0.001 |
| Cough | 71 (11) | 8 (1) | <0.001 |
| Cardiologic | |||
| Palpitations | 18 (3) | 13 (2) | 0.588 |
| Fatigue | 56 (9) | 5 (1) | <0.001 |
| Muscle pain | 49 (8) | 8 (1) | <0.001 |
| Loss of weight | 51 (8) | 7 (1) | <0.001 |
a
Anxiety, mood swings, depression, headache, dizziness, loss of smell, loss of taste, forgetfulness, and difficulty concentrating were requested only in children ≥5 years (cases, n = 388 and controls, n = 447).
b
Fisher's exact test. N (%) are shown.